What is he best known for?
The fields of study he is best known for:
- Gene
- Neurotransmitter
- Dopamine
David Sulzer spends much of his time researching Dopamine, Neuroscience, Dopaminergic, Cell biology and Synaptic vesicle.
His Dopamine research incorporates themes from Catecholamine, Neuron and Neurotransmitter.
His work in Neuroscience tackles topics such as Neurotransmission which are related to areas like Reuptake.
His work deals with themes such as Autophagy, Chaperone-mediated autophagy, Neurotoxicity, Alpha-synuclein and Biochemistry, which intersect with Cell biology.
David Sulzer combines subjects such as BECN1, Autophagosome, Autophagy database, MAP1LC3B and Computational biology with his study of Chaperone-mediated autophagy.
His Synaptic vesicle research is multidisciplinary, relying on both Methamphetamine and Exocytosis.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (1951 citations)
What are the main themes of his work throughout his whole career to date?
David Sulzer mainly investigates Neuroscience, Dopamine, Dopaminergic, Cell biology and Substantia nigra.
His Neuroscience study frequently involves adjacent topics like Glutamate receptor.
His research integrates issues of Synaptic vesicle, Neurotransmission and Neurotransmitter in his study of Dopamine.
His studies deal with areas such as Neurotoxicity, Dopamine receptor D2 and Pharmacology as well as Dopaminergic.
David Sulzer has included themes like Autophagy, Biochemistry and Alpha-synuclein in his Cell biology study.
His Substantia nigra research incorporates elements of Neurodegeneration and Neuroprotection.
He most often published in these fields:
- Neuroscience (49.43%)
- Dopamine (50.57%)
- Dopaminergic (27.00%)
What were the highlights of his more recent work (between 2017-2021)?
- Neuroscience (49.43%)
- Dopamine (50.57%)
- Striatum (10.27%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Neuroscience, Dopamine, Striatum, Parkinson's disease and Autophagy.
His Neuroscience study integrates concerns from other disciplines, such as Neurotransmission and Alpha-synuclein.
His study in Dopamine focuses on Substantia nigra and Dopaminergic.
His research in Parkinson's disease intersects with topics in Endocrinology and Pharmacology.
His work carried out in the field of Autophagy brings together such families of science as Regulator, PI3K/AKT/mTOR pathway and Function, Cell biology.
The various areas that he examines in his Cell biology study include Translation, EIF4E, Ribosome profiling and Chaperone-mediated autophagy.
Between 2017 and 2021, his most popular works were:
- Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease (72 citations)
- Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations (61 citations)
- The Physiological Role of α‐Synuclein and Its Relationship to Parkinson's Disease (56 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Neurotransmitter
- Neuron
Neuroscience, Parkinson's disease, Neuromelanin, Autophagy and Substantia nigra are his primary areas of study.
His Neuroscience research integrates issues from Postsynaptic potential and Serotonin.
His Neuromelanin research is multidisciplinary, incorporating elements of Biochemistry, Organelle, Autolysosome, Human brain and Lipid Transport.
His work on Autolysosome is being expanded to include thematically relevant topics such as Cell biology.
His Substantia nigra research includes elements of Oxidative stress and Neurodegeneration.
His Striatum study is concerned with the larger field of Dopamine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
